Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition that significantly impairs pulmonary function and quality of life. In the medical-surgical nursing setting, effective management of COPD involves a combination of respiratory support, medication administration, patient education, and complication prevention. This article outlines the pathophysiology, clinical manifestations, diagnostic procedures, and comprehensive nursing interventions essential for managing COPD. Emphasis is placed on airway clearance techniques, nutritional support, lifestyle modification, and the nurse’s role during acute exacerbations.

• 1.   Black, J. M., & Hawks, J. H. (2019). MedicalSurgical Nursing: Clinical Management for Positive Outcomes (10th ed.). Elsevier.
• 2.   Lewis, S. L., Dirksen, S. R., Heitkemper, M. M., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems (11th ed.). Elsevier.
• 3.   Smeltzer, S. C., Bare, B. G., Hinkle, J. L., & Cheever, K. H. (2021). Brunner & Suddarth’s Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer.
• 4.   Ignatavicius, D. D., Workman, M. L., & Rebar, C. R. (2021). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care (10th ed.). Elsevier.
• 5.   Gulanick, M., & Myers, J. L. (2021). Nursing Care Plans: Diagnoses, Interventions, and Outcomes (9th ed.). Elsevier.
• 6.   Huether, S. E., & McCance, K. L. (2020). Understanding Pathophysiology (7th ed.). Elsevier.
• 7.   McKinney, E. S., James, S. R., Murray, S. S., Nelson, K. A., & Ashwill, J. W. (2022). MaternalChild Nursing (6th ed.). Elsevier.
• 8.   Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global Strategy for the Diagnosis, Management, and Prevention of COPD. https://goldcopd.org.
• 9.   American Lung Association. (2023). Chronic Obstructive Pulmonary Disease (COPD). https://www.lung.org/lung-health-diseases/ lung-disease-lookup/copd
• 10.   National Heart, Lung, and Blood Institute (NHLBI). (2023). What is COPD? https:// www.nhlbi.nih.gov/health/copd
• 11.   Mayo Clinic. (2023). COPD – Symptoms and Causes. https://www.mayoclinic.org/ diseases-conditions/copd
• 12.   Vogelmeier, C. F., et al. (2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 195(5), 557–582.
• 13.   Wark, P. A., McDonald, V. M., & Gibson, P. G. (2020). Adult asthma and chronic obstructive pulmonary disease. The Lancet Respiratory Medicine, 8(3), 295–312.
• 14.   O’Donnell, D. E., & Laveneziana, P. (2021). Dyspnea and activity limitation in COPD. Chest, 160(1), 243–254.
• 15.   Spruit, M. A., et al. (2013). An official ATS/ ERS statement: Key concepts and advances in pulmonary rehabilitation. AJRCCM, 188(8), e13–e64.
• 16.   Singh, D., et al. (2019). Inhaled corticosteroids in COPD: A narrative review. Respiratory Research, 20, 1–9.
• 17.   Mahler, D. A., & O’Donnell, D. E. (2016). Recent advances in dyspnea. Chest, 150(4), 1063–1077.
• 18.   Criner, G. J., & Han, M. K. (2018). COPD care in the 21st century. New England Journal of Medicine, 378(19), 1855–1856.
• 19.   Bourbeau, J., et al. (2003). Reduction of hospital utilization in COPD: A disease-specific selfmanagement intervention. Archives of Internal Medicine, 163(5), 585–591.
• 20.   Yohannes, A. M., & Alexopoulos, G. S. (2014). Depression and anxiety in patients with COPD. European Respiratory Review, 23(133), 345–349.
• 21.   Garcia-Aymerich, J., et al. (2006). Physical activity and clinical status in COPD. Chest, 129(2), 353–360. 22. Hurst, J. R., et al. (2010). Susceptibility to exacerbation in COPD. New England Journal of Medicine, 363(12), 1128–1138.
• 23.   Casey, D., Murphy, K., Devane, D., Cooney, A., & Hunter, A. (2011). A qualitative study exploring the evidence-based practice of respiratory nurses. Journal of Clinical Nursing, 20(5–6), 776–788.
• 24.   Lareau, S. C., Fahy, B., Meek, P., & Wang, A. (2020). Patient education in COPD: Time for a new approach? Chronic Respiratory Disease, 17, 1–9.
• 25.   Wedzicha, J. A., & Seemungal, T. A. (2007). COPD exacerbations: Defining their cause and prevention. The Lancet, 370(9589), 786–796.
• 27.   Pauwels, R. A., et al. (2001). Global strategy for diagnosis, management, and prevention of COPD. American Journal of Respiratory and Critical Care Medicine, 163(5), 1256– 1276.
• 28.   Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD. European Respiratory Journal, 23(6), 932–946.
• 29.   Jenkins, C. R., et al. (2017). Quality of life and adherence in COPD: Results from a crosssectional survey. BMC Pulmonary Medicine, 17(1), 1–9.
• 30.   Effing, T. W., et al. (2012). Self-management education for patients with COPD. Cochrane Database of Systematic Reviews, (5), CD002990.

Data Sharing Statement

Funding